Pulmonary hypertension (PH) is an uncommon but progressive condition, and much of what we know about it comes from specialized disease registries. With expanding research into the diagnosis and treatment of PH, it is important to provide updated surveillance on the impact of this disease on hospitalizations and mortality. This study, which builds on previous PH surveillance of mortality and hospitalization, analyzed mortality data from the National Vital 
Trend analyses and comparability tests for age-standardized or agespecifi c death rates plotted over time by year were conducted using Joinpoint soft ware, developed by the National Cancer Institute. (Joinpoint version 4.0.3; National Cancer Institute). Th e number of trend segments is based on a segmented line regression analysis of best fi t with the smallest number of "joinpoints" or points (0 or 1) at which the direction of the trend line changes. Annual percent change (APC) was calculated for each of the trend segments. Average annual percent change (AAPC) was calculated for the time period 2001 to 2010 to quantify the average trend over this time period. To determine whether the trend lines were parallel or coincident, tests were conducted to assess pairwise diff erences between race/ethnicity, with NH white as the referent; age-specifi c diff erences, with 0 to 12 months as the referent; and sex diff erences, with men as the referent. Tests determined whether (1) two joinpoint regression functions were identical (test of coincidence) or (2) two regression mean functions were parallel (test of parallelism) at P , .05.
Th e distribution of selected disease categories reported as the underlying cause of death (UCOD) among decedents with reported PH was examined for 2001 through 2010 by race/ethnicity and sex. Rates and trends for these distributions were calculated over that time period.
Hospitalizations
The NHDS, conducted annually from 1965 to 2010 by the Centers for Disease Control and Prevention's National Center for Health to 2002 identifi ed decreasing mortality rates associated with PH among men, but increasing mortality rates among women, along with stable rates among whites but increasing rates among blacks. Increasing rates of hospitalization associated with PH were identifi ed as well. Th e symptoms of PH during the initial stage of the disease are common to many other medical conditions (eg, diffi culty breathing, fatigue), oft en resulting in a delayed diagnosis until more severe symptoms arise (eg, dizziness, chest pain, ankle swelling, palpitations). 3, 4 PH is characterized by increased pressure in the pulmonary arteries (resting mean pulmonary artery pressure Ն 25 mm Hg) and increased pulmonary arterial resistance but it is associated with many underlying conditions. 5 Th e World Health Organization classifi cation of PH, known as the Dana Point classifi cation, was last updated in 2008 6 ( Table 1 ) , aft er the most recent PH surveillance summary from the Centers for Disease Control and Prevention. 2 Some common underlying causes include pulmonary arterial hypertension (PAH) from congenital heart disease, connective tissue disease, or persistent PH of the newborn; PH due to left -sided heart disease; chronic lung diseases and hypoxemia; and chronic thromboembolic pulmonary disease. Genetics also plays a role in PH, and although PH occurs at all ages, the incidence increases with age. Registries from France and the United Kingdom report an incidence rate of 1.1 to 2.4 cases per million population per year, a prevalence of 6.6 to 15.0 cases per million population per year for PAH, and a 5-year mortality of approximately 40%. 7 Much of what we know about PH comes from specialized disease registries. [8] [9] [10] With expanding research into the diagnosis and treatment of PH, it is important to provide updated surveillance on the impact of this disease on hospitalizations and mortality. Th e surveil-
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lance report by Hyduk et al 2 described trends in mortality and hospitalization rates associated with PH among adults aged 45 years and older from 1980 through 2002 by demographic characteristics. Th is study builds on previous PH surveillance of mortality and hospitalization using data from the National Vital Statistics System and the National Hospital Discharge Survey (NHDS). 11 Th e purpose of our report is to describe trends in diagnosed PH-related mortality and hospitalizations during the period 2001 to 2010. Because PH is frequently reported as a secondary diagnosis, our report presents data for PH as any contributing cause of death or as any listed hospital diagnosis. Statistics, is a national probability sample survey of hospital discharge information abstracted from the medical records of inpatients from nonfederal, short-stay general hospitals in the United States. 15 Only hospitals with an average length of stay of fewer than 30 days for all patients, and general and children's general hospitals, were included in the survey. Excluded were federal, military, and Veterans Aff airs hospitals, as well as hospital units of institutions, such as prison hospitals, and hospitals with fewer than six beds staff ed for patient use. NHDS data from 2001 to 2010 were analyzed in fi ve 2-year increments (2001-2002, 2003-2004, 2005-2006, 2007-2008, and 2009-2010) . Annual discharge and population estimates were combined in 2-year intervals to increase the reliability of rate estimates. Th is report provides estimates of the number and rates of hospitalization discharges attributed to PH, defi ned as having any one of up to seven listed medical diagnoses with an International Classifi cation of Diseases, Ninth Revision, Clinical Modifi cation (ICD-9-CM) code of 416.0, 416.8, or 416.9. In 2010, a change occurred in the ICD-9-CM codes for PH, with the addition of a code for chronic pulmonary embolism (416.2). Estimates of the number and rate of hospitalizations associated with PH were calculated by using weights (ie, infl ation factors) that allowed national estimation from the sample. More details about the design of NHDS have been published elsewhere. 15 Because people with multiple discharges during the year may be sampled more than once, esti mates are for hospital discharges, not persons. Data for newborn infants, defi ned as patients admitted to a hospital by birth, were excluded from this report.
Results

Mortality
Th e death rate for PH as any contributing cause of death was 5.5 per 100,000 in 2001 and 6.5 per 100,000 in 2010 ( Tables 3, 4 ). PH death rates for men and women were the same in 2001 (5.6 per 100,000). Although rates have increased for both men and women, the AAPC in death rates from 2001 to 2010 shows that rates rose more sharply for women (AAPC, 2.5; P , .05) than for men (AAPC, 0.9; P , .05) ( Fig 2 , Table 5 ).
From 2001 to 2010, PH death rates were consistently higher for NH blacks than for NH whites (2010 rate, 9.1 per 100,000 for NH blacks vs 6.5 per 100,000 for NH whites) ( Tables 3, 4 ). When compared with those for NH whites, PH death rates for NH AI/AN, NH Asian/ Pacifi c Islanders, and Hispanics were consistently either lower or not statistically signifi cantly diff erent. However, it should be noted that because of concerns regarding the accuracy of coding race/ethnicity on death certifi cates, the comparisons of NH whites with race/ ethnic groups other than NH blacks are provided with caution on interpretation. 18 PH death rates increased over time for all races/ethnicities ( Fig 3 , Table 6 Death rates for PH were highest in the oldest age group (85 years and older) for every year ( Tables 7, 8 ) and increased by Ͼ 65% between 2001 and 2010 (65.6 per 100,000 to 108.7 per 100,000). PH death rates in the 0-to 12-month age group were higher in 2001 (14.9 per 100,000) than in 2010 (8.2 per 100,000). Th e PH death rate trend analysis by age group for 2001 to 2010 shows diff erences in the direction of the slope segments ( Fig 4 ,  Table 9 ). Neonates through 12 months had the only statistically signifi cant decrease in rates (APC, 2 6.9; P , .05). Th e greatest increases in PH death rates were among the oldest age group (85 years and older) from Intercensal estimates of the US noninstitutionalized civilian population from 2001 to 2002 to 2009 to 2010 were provided by the US Bureau of the Census and were used to calculate age-and sex-specifi c hospitalization rates per 100,000 people. Age-specifi c hospitalization rates were calculated for those aged , 35 years, 35 to 44 years, 45 to 54 years, 55 to 64 years, 65 to 74 years, 75 to 84 years, and Ն 85 years. Hospitalization rates were also directly age standardized to the 2000 US standard population using seven age groups. 16 Race-specifi c estimates are not provided because of incomplete reporting of race on hospital records.
In addition, the distribution of selected disease categories as the principal (ie, fi rst listed) diagnosis was examined for each period among hospitalizations with any listed PH, and the average lengths of stay for PH-related hospitalizations were compared by age group. Average length of stay was estimated as the ratio of total days of care per discharge to the total number of discharges.
A weighted least-squares regression method 17 was used to test for linear trends in hospitalization rates. A P value of , .05 indicated statistical signifi cance. Diff erences among subgroups were evaluated using unrounded numbers with two-tailed t tests. Data analyses were performed using the statistical packages SAS, versions 9.2 and 9.3 (SAS Institute Inc), and SUDAAN, versions 10.0 and 11.0 (Research Triangle Institute). See Table 3 legend for expansion of abbreviations. The National Vital Statistics System was used to ascertain deaths due to pulmonary hypertension, which were considered those with decedents having ICD-10 codes I27.0, I27.2, I27.8, or I27.9 reported as any contributing cause of death (ie, any of the possible 20 conditions, including the underlying cause of death). AAPCs are provided for the time period 2001 to 2010; the joinpoint varies and is based on the joinpoint regression analysis of best fi t with the smallest number of deaths. Rates are per 100,000 population and are age standardized to the 2000 US standard population (eight age groups). AAPC 5 average annual percent change; APC 5 annual percent change. See Table 2 In 2001, the most common UCOD among decedents with PH listed as any contributing cause of death was PH (29.3%), followed by chronic lower respiratory disease (26.2%), coronary heart disease (8.8%), and interstitial lung disease (4.5%) ( Table 10 ). Within the category of chronic lower respiratory disease, emphysema was indicated in 4.2% of deaths ( Table 10 ) . Th e most commonly reported underlying causes of death for all race/sex groups were PH and chronic lower respiratory disease.
In 2010, PH (at 30.2%) was the most common UCOD among decedents with PH listed as any cause of death, followed by chronic lower respiratory disease (19.0%), coronary heart disease (10.3%), and interstitial lung disease (4.9%) ( Table 11 ). Interestingly, from 2001 to 2010, the percentage of PH deaths caused by emphysema dropped from 4.2% to 1.4% of all PH deaths, whereas PH deaths caused by nonrheumatic valvular heart disease rose from 2.6% in 2001 to 4.1% in in 2010. Autoimmune diseases listed as the UCOD were higher for women than for men regardless of race or Hispanic origin.
Th e UCOD associated with PH showed several interesting trends ( Table 12 ) . Th e AAPC increased significantly for several UCOD conditions, including coronary heart disease, aortic stenosis, hypertension, autoimmune disease, infl uenza, and pneumonia; it showed no signifi cant change for malignancies of the trachea and bronchus;
and it decreased for heart failure, chronic lower respiratory disease (emphysema in particular), and congenital malformations. The National Vital Statistics System was used to ascertain deaths due to pulmonary hypertension, which were considered those with decedents having ICD-10 codes I27.0, I27.2, I27.8, or I27.9 reported as any contributing cause of death (ie, any of the possible 20 conditions, including the underlying cause of death). See Table 2 , 3 , and 5 legends for expansion of abbreviations. a AAPC is signifi cantly diff erent from zero at a 5 0.05. b APC is signifi cantly diff erent from zero at a 5 0.05. See Table 3 legend for expansion of abbreviation.
from 91 per 100,000 discharges to 131 per 100,000 discharges ( P , .001). Th e rate of hospitalization for women increased by 52%, from 97 per 100,000 to 147 per 100,000 ( P , .001). Th e rate of hospitalization for men increased by 33%, from 83 per 100,000 to 110 per 100,000 ( P , .01). Crude and age-adjusted hospitalization rates were both higher for women than for men at each time interval, except for 2007 to 2008 ( P , .05) ( Table 9 for additional data. See Figure 2 legend for expansion of abbreviation.
(606 in 2001 to 1,173 in 2010; P , .01) ( Table 13 ) . Among women, the rate of hospitalization increased for almost all age groups ( , 35 years, 45-54 years, 75-84 years, and Ն 85 years) ( Table 13 ) . Th e hospitalization rate for women , 35 years old was the lowest among all women and had the greatest percentage increase over time. ( Table 14 ) .
Th e three most commonly reported principal diagnoses at inpatient discharges with any listed PH remained the same throughout the 10-year period ( Table 15 ) . Th e most common principal diagnosis was congestive heart failure, followed by other heart diseases (which included PH) and chronic and unspecifi ed bronchitis. Congestive heart failure was the primary diagnosis for 19% of the , the average length of stay for hospitalizations for those aged , 35 years was signifi cantly longer than for any other age group. In 2009 to 2010, signifi cantly more men than women were discharged home ( P , .02), and signifi cantly more women than men were discharged to long-term care ( P , .001) ( Fig 7 ) . As age increased, the percentage discharged to home decreased.
Discussion
Th e fi ndings in our report indicate signifi cant increases in death rates associated with PH for women, men, all racial/ethnic groups, and especially among those aged 75 years and older. Considering all PH deaths from 2001 to 2010, we identifi ed signifi cant decreases from PH associated with chronic lower respiratory disease (including emphysema specifi cally), conditions arising in the perinatal period, congenital malformations, and pulmonary embolism. At the same time, we identifi ed increases from 2001 to 2010 in death rates for PH associated with aortic stenosis, hypertension, coronary heart disease, autoimmune diseases, diabetes, renal disease, and chronic liver disease. Given that PH mortality due to chronic lower respiratory disease represents a significant proportion of total PH mortality, the decline from The National Vital Statistics System was used to ascertain deaths due to pulmonary hypertension, which were considered those with decedents having ICD-10 codes I27.0, I27.2, I27.8, or I27.9 reported as any contributing cause of death (ie, any of the possible 20 conditions, including the underlying cause of death). Rates are per 100,000 population and age-specifi c death rates were calculated for each of six age groups. See Table 2 2001 to 2010 in these death rates may be aff ecting the increasing rates identifi ed with other PH-associated conditions; therefore, the signifi cant rates associated with other conditions such as aortic stenosis, hypertension, diabetes, renal disease, and chronic liver disease should be interpreted with caution, given their individually smaller contributions to total PH mortality.
Death rates among those Ն 85 years old have increased rapidly since 2001. Th e Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) compared demographics from their data on patients with group 1 PAH with those from a National Institutes of Health (NIH) registry from 1982. Th ey found that their current registry patients had a mean age of 45 years compared with 36 years in the NIH registry in 1982, and a higher prevalence of women (78% vs 63%). 18 Diff erences in death rates by sex and race/ethnicity were reported previously, 2, 19, 20 and this report adds important new information about those trends. A previous report 2 showed that the trend in the PH mortality rate for men actually declined from 1980 through 2002; information in this report shows that the rates for men continued to decline until 2006 and then began increasing. In general, between 2001 and 2010, mortality rates from COPD declined among men 12 and this may explain, in part, the long-term decline in mortality among men with PH that was trending from 1980 to 2006. Reasons for the reversal in trend for men are unclear, but the previous decline may have been associated with reductions in COPD and emphysema, which the current analysis identifi es as well. On the other hand, we identifi ed increases in the rates of PH mortality in association with coronary heart disease and hypertension as well as autoimmune disease in men. Few studies have found male sex to be a risk factor for death among patients with PH associated with autoimmune disease. 21 Death rates associated with PH for women from 2001 to 2010 were consistently higher than those for men. Th ese sex diff erences are consistent with data from the REVEAL Registry, in which the patients were more likely to be women. 18 Women have higher rates of connective tissue disease than do men. 22 Th e French National Pulmonary Hypertension registry found that women have higher rates of idiopathic and inherited PH compared with men. 23 In the REVEAL Registry, which includes only patients with PAH, it was found that roughly one-half of patients with PAH had idiopathic PAH and one-half had associated PAH, with connective tissue disease accounting for roughly 25% of the patients in the registry. 24 With current ICD-10 mortality codes, there are challenges in separating PAH as idiopathic vs associated ( Fig 1 , Table 2 ). Indeed, most causes of death from PH in the multiple cause of death fi les are listed as "other secondary PH" or "PH, not otherwise specifi ed." Few cases are listed as "primary PH." In a retrospective cohort study of 55 patients with PAH, Kawut et al 25 found that patients with systemic sclerosis associated with PH had a higher risk of death despite having similar demographic and hemodynamic characteristics. Research is also ongoing regarding a hormonal mechanism that may explain the sex diff erences. 9, 26 Diff erential sex exposure to anorexigens may also help explain some sex diff erences, 18 although it is unclear to what extent this applies to the US population.
Mortality rates for blacks are increasing at a greater rate than they are for whites. Th e race/sex diff erences found in these data are consistent with data from the REVEAL Registry, which noted that the greatest ratios of female to male patients in the registry by race/ethnicity were among blacks and the lowest were among whites. 18 In addition to increased connective tissue disease among black women , blacks in general have higher rates of connective tissue disease, hypertension, and hemoglobinopathies in association with PH than do whites. 22 Mortality data for all decedents with PH listed on the death certifi cate are consistent with a widening race/sex gap in recent years, although age-adjusted race/sex mortality gaps are less prominent than are patient ratios in the REVEAL Registry, which is not age adjusted and only includes PAH. Diff erential race/ethnicity changes over time may also be related to changing population demographics for PH mortality over the past decades. Previous studies have reported that blacks have a shorter survival from the time of diagnosis of PH, 27 and have higher rates of PH associated with connective tissue disease. Our fi ndings of increasing rates of PH mortality associated with hypertension, diabetes, and renal failure may also contribute to the racial gap in PH mortality. Poms et al 28 found that those with PAH and diabetes have decreased survival.
Although they did not report on race/ethnicity associations of PH with chronic kidney disease, Bolignano et al 29 suggested that renal failure itself may be a trigger for PH. Overall mortality from diabetes (listed as the UCOD) declined from 2001 to 2010, 30 whereas deaths from diabetes in patients with PH have increased.
Interestingly, the geographic pattern of PH death rates by state does not mirror the patterns seen in maps showing all heart disease deaths, where the highest rates Estimate does not meet standards of reliability or precision. The National Center for Health Statistics considers an estimate to be reliable if it is based on at least 30 discharge records and it has a relative SE of Յ 30% (ie, the SE is Յ 30% of the estimate). are typically located in the deep south and the lowest rates in the northwest. 31 Th is highlights the diff erences in risk factors and populations at risk of PH.
We also found increasing hospitalization rates for both men and women, and there has been some shift in the most common primary reason for admission. Although heart failure is the most common underlying reason for admission associated with PH, the proportion of hospitalizations for heart failure associated with PH has declined, as have most major reasons for hospitalization associated with PH. Yet hospitalizations for asthma, renal conditions, and the category of less common conditions associated with PH have increased. Th is may refl ect better documentation, but it may also suggest important changes in the underlying conditions associated with PH.
Th e fact that we found that women have twice as many hospitalizations associated with PH than do men likely refl ects the diff erence in life expectancy but also the disproportionate burden of PH disease experienced by women. Compared with the previous report covering 1980 to 2002, women continue to have higher rates of hospitalizations than do men, and the greatest increase in rates over time is in the oldest age group. For women, increases in the PH hospitalization rate were noted across most age groups, whereas for men, the rate increased only among those Ն 85 years old. Most hospitalizations for those Ն 85 years old were among women. Discharge status is likely infl uenced by these demographic differences, with more women discharged to long-term care and more men discharged to their home.
Although some of the increase in mortality from PHassociated conditions may be explained by a heightened awareness of PH and referral to specialists able to make the diagnosis, the signifi cant declines in mortality from 32 Given the accelerating rate of mortality among those aged Ն 85 years, the overall increase in mortality from PH may refl ect diff erent characteristics of disease manifestation among the older patients with additional comorbid conditions. Canadian researchers found that patients Ն 65 years old were more likely to have PH associated with scleroderma than were younger patients, although they also noted that younger patients with PH associated with scleroderma were more likely to die during a median follow-up of 3 years. 33 Th is report is subject to several limitations related to both mortality and hospitalization data. First, death certifi cates may not accurately capture the UCOD or contributing causes of death because of inaccuracy of diagnosis or limited knowledge of the deceased's medical history by the person completing the death certificate. Th is limitation may result in underreporting of PH on death certifi cates. Second, race and ethnicity may not be accurately captured on death certifi cates or hospitalization data, especially for Hispanics and races other than black or white. Th is may aff ect the observed mortality and hospitalization rates for Hispanics and other nonwhite/nonblack individuals, especially AI/AN decedents. 14 Th ird, comparisons of mortality data with epidemiologic data from disease registries are limited by the fact that some disease registries are prevalence registries, whereas others are incident registries, or they separate incident and prevalent cases, and by the fact that disease registries are predominately for PAH rather than for all PH causes. Fourth, although trends in UCOD over time can be identifi ed, secular changes in the incidence or prevalence of the diseases reported as the UCOD over time are not refl ected in the mortality trends shown here. Th erefore, these trends must be interpreted with caution. Fift h, the NHDS does not include patients admitted to federal, military or Veterans Aff airs hospitals; therefore, results underestimate the total number of hospitalizations for PH among adults. Sixth, unfortunately, the terminology used in the ICD and ICD-CM does not crosswalk easily with the Dana Point classifi cation of PH, and although using the identical fourth digits in both the ICD-9-CM and the ICD-10, the descriptions do not crosswalk well with each other, nor do they crosswalk well with the Dana Point PH classifi cation of PH. Th is contributes to challenges in correct classifi cation of causes of death and hospital diagnoses. Lastly, the NHDS increased the number of diagnoses collected in 2010 from seven to 15 . Th e number of diagnoses collected has a signifi cant impact on estimates, particularly for conditions that are Numbers are presented in thousands. See Table 2 legend for expansion of abbreviations. (Adapted with permission from Centers for Disease Control and Prevention, National Center for Health Statistics. 11 ) a Estimate does not meet standards of reliability or precision. The National Center for Health Statistics considers an estimate to be reliable if it is based on at least 30 discharge records and it has a relative SE of Յ 30% (ie, the SE is Յ 30% of the estimate).
typically secondary diagnoses such as PH. Larger percentage diff erences can be seen in hospitalizations for older people, who are more likely to carry multiple diagnoses. Th e estimated number of PH hospitalizations in 2010 using seven diagnoses was 471,864, but the estimate increased to 728, 983 when using 15 diagnoses (a 54% increase in the estimated number of hospitalizations [ Table 16 ]). For those aged 85 years and older, there is a 66% increase in the estimated number of hospitalizations if 15 diagnoses are used, compared with seven diagnoses. Th is analysis helps explain diff erences in previously reported hospitalizations associated with PH from the Healthcare Cost and Utilization Project on hospital stays related to PH. 34 
Conclusions
Our report documents increases in mortality associated with PH among men, women, and all race and ethnic groups, and from several conditions commonly associated with PH (hypertension and coronary heart disease, aortic stenosis, liver disease and cirrhosis, and autoimmune disease) but also from renal disease and diabetes, while fi nding that PH-associated mortality decreased over time from deaths due to congenital malformations among newborns, and for emphysema, chronic lower respiratory disease, and pulmonary embolism. Approximately one-half of deaths associated with PH occur among those under 75 years of age. Although PH death rates have been stable for those aged 1 to 74 years over the past decade, the identifi ed increases in PH death among those with a UCOD from hypertension, coronary heart disease, and valvular disease may be avoidable with improved public health eff orts in the primary prevention of heart disease. Th e increased mortality from autoimmune conditions in association with PH requires further study. Increases in hospitalizations may refl ect both improved recognition of PH as well as an increase in treatment options. Th e decline in PH mortality due to congenital malformations, chronic lower respiratory disease, and emphysema over time is encouraging. Th e ability to code mortality and hospitalizations using a modifi ed diagnostic classifi cation based on the fi ve major classes in the Dana Point classifi cation could improve the surveillance of PH, which would also aid in understanding age, race, and sex diff erences in PH mortality.
